Post-Market Clinical Follow-Up (PMCF) Services (EU MDR Compliance)
Our Post-Market Clinical Follow-Up (PMCF) services support medical device manufacturers in meeting EU MDR requirements for ongoing clinical evaluation. Patient Guard provides expert guidance to ensure your PMCF activities demonstrate safety, performance, and continued compliance throughout the product lifecycle.
Post-Market Clinical Follow-Up (PMCF) Services
Post-Market Clinical Follow-Up (PMCF) is a mandatory requirement under EU MDR (EU 2017/745), forming a key part of your Post-Market Surveillance (PMS) system and Clinical Evaluation.
PMCF involves the proactive collection and evaluation of clinical data after a device has been placed on the market to confirm safety and performance and identify emerging risks.
Manufacturers must establish and maintain a PMCF plan, collect relevant clinical data, and document findings in a PMCF Evaluation Report (PMCFER).
Patient Guard acts as your PMCF consultancy partner, supporting the development, execution, and maintenance of compliant PMCF activities aligned with EU MDR, MEDDEV 2.7/1 Rev. 4 and MDCG guidance expectations.
Without a robust PMCF system, manufacturers risk non-conformities, Notified Body findings, and potential delays in CE marking or recertification.
Patient Guard provides expert PMCF services tailored to your device classification, risk profile, and clinical strategy. We ensure your PMCF activities are proportionate, justified, and fully compliant.
New to the EU Medical Device Regulation (MDR)?
This page explains Patient Guard’s Post-Market Clinical Follow-up (PMCF) services, helping manufacturers meet the ongoing clinical evidence requirements of EU MDR 2017/745. If you're looking for a broader introduction to the Medical Device Regulation, including CE marking, Clinical Evaluation, Risk Management, Technical Documentation, Post-Market Surveillance and the role of PMCF under Annex XIV, read our MDR for Beginners – Complete Guide.
Why Choose Patient Guard for PMCF?
Clinical and regulatory expertise
We align PMCF activities with EU MDR, MEDDEV, and Notified Body expectations.
Established regulatory consultancy since 2017
We specialise in clinical evaluation and EU MDR compliance.
Trusted by 500+ companies
We support manufacturers across all device classes and technologies.
Proportionate and efficient strategies
We design PMCF plans that are compliant without being unnecessarily burdensome.
End-to-end support
From planning through to reporting and updates.
Transparent pricing
Clear project-based pricing with no hidden costs.
What Our PMCF Service Includes
Clinical and regulatory expertise
We align PMCF activities with EU MDR, MEDDEV, and Notified Body expectations.
PMCF Plan development
We develop a compliant PMCF Plan aligned with Annex XIV Part B of EU MDR.
PMCF strategy and justification
We support manufacturers across all device classes and technologies.
Clinical data collection planning
We identify appropriate data sources such as literature, registries, surveys, or clinical investigations.
PMCF Evaluation Report (PMCFER)
We prepare compliant PMCF reports summarising findings and conclusions.
Integration with Clinical Evaluation
We ensure PMCF outputs are aligned with your Clinical Evaluation Report (CER).
Post-Market Surveillance integration
We align PMCF with your PMS and vigilance systems.
Ongoing updates and maintenance
We support periodic PMCF updates and regulatory compliance.
Who Requires PMCF?
- Medical device manufacturers under EU MDR
- Class IIa, IIb, and III device manufacturers
- Manufacturers undergoing CE marking or recertification
- Companies with higher-risk or implantable devices
- Organisations with insufficient pre-market clinical data
EU MDR PMCF Requirements
Under EU MDR Annex XIV Part B, manufacturers must:
- Establish a PMCF Plan
- Proactively collect and evaluate clinical data
- Analyse safety and performance during real-world use
- Document findings in a PMCF Evaluation Report
- Update clinical evaluation and risk management documentation
PMCF is essential for demonstrating ongoing safety, performance, and benefit-risk acceptability.
Our Process
Step 1 – Assessment & Planning
We assess your device, classification, and existing clinical data, then develop a compliant PMCF Plan and strategy
Step 2 – Execution & Data Collection
We support PMCF activities including clinical data collection, literature review, and real-world evidence gathering
Step 3 – Reporting & Ongoing Compliance
We prepare the PMCF Evaluation Report (PMCFER) and align outputs with CER, PMS, and risk management, ensuring continued compliance
Industries We Support
We support PMCF services across:
- Medical device manufacturers
- Implantable device companies
- Digital health and SaMD
- Start-ups and global manufacturers
Cost of Service
Post Market Clinical Follow-up (PMCF) Services
ph
Ensure ongoing EU MDR compliance with expert Post-Market Clinical Follow-up (PMCF) support. Patient Guard develops PMCF plans, supports clinical data collection, and prepares PMCF Evaluation Reports to demonstrate continued safety, performance, and benefit-risk acceptability.
Features
- PMCF Plan development aligned with EU MDR Annex XIV Part B
- Clinical data collection strategy, including literature, surveys, registries, and real-world evidence
- PMCF Evaluation Report preparation to support CER and PMS updates
- Integration with Clinical Evaluation, Post-Market Surveillance, and Risk Management documentation
Time Lines
Weeks 1–2 – Assessment & PMCF Planning
Assess device classification, existing clinical data, and develop the PMCF Plan and strategy
Weeks 3–8 – Data Collection & Analysis
Support PMCF activities, including literature review, surveys, registry data, or real-world evidence collection
Weeks 9–12 – PMCF Reporting & Updates
Prepare the PMCF Evaluation Report and align outputs with CER, PMS, and risk management documentation
Frequently Asked Questions (FAQs)
What is PMCF?
PMCF is the continuous process of collecting clinical data after a device is placed on the market to confirm safety and performance.
Is PMCF mandatory under EU MDR?
Yes, PMCF is a requirement for most medical devices under EU MDR, particularly for Class IIa and above.
Do all devices require PMCF studies?
Not necessarily. PMCF activities must be justified and proportionate to the device risk and available clinical data.
What is a PMCF Evaluation Report?
A PMCFER summarises the results of PMCF activities and confirms whether the device continues to meet safety and performance requirements.
How often should PMCF be updated?
PMCF should be updated regularly as part of your PMS and clinical evaluation cycle.
Related Services
Click on the links below to discover more:
Do you need Training?
Check out Patient Guards Training Courses
Recent Blog Posts
Why Notified Bodies Reject IVDR Performance Evaluation Reports: The Top 3 Mistakes Manufacturers Make
More than half of IVDR submissions face deficiencies during Notified Body review, with Performance Evaluation Reports (PERs) among the most common areas of concern. Learn the three critical mistakes that lead to PER rejections—including weak State of the Art justification, non-systematic literature reviews, and poor traceability between Scientific Validity, Analytical Performance, and Clinical Performance data—and discover how to build a compliant, audit-ready IVDR technical file.
10 Common Technical Documentation Deficiencies Found During EU MDR and IVDR Notified Body Reviews
Preparing technical documentation for EU MDR or IVDR certification is only half the challenge. Successfully passing a Notified Body review depends on demonstrating consistency across your Quality Management System, Clinical Evaluation, Risk Management, Biological Evaluation, Performance Evaluation and Post-Market Surveillance activities. Discover ten of the most common technical documentation deficiencies identified during MDR and IVDR conformity assessments—and learn how to reduce the likelihood of costly review cycles and certification delays.
EU Authorised Representative Services for Medical Device & IVD Manufacturers
Selling medical devices or IVDs in Europe? If your company is based outside the EU, appointing an EU Authorised Representative (EC Rep) is a legal requirement under EU MDR 2017/745 and IVDR 2017/746. Patient Guard provides expert EU Authorised Representative services, EUDAMED support, regulatory guidance, and ongoing compliance management to help manufacturers access and maintain the European market with confidence.
Predetermined Change Control Plans (PCCPs): The Future of Agile Compliance for Medical Device Software
Learn how PCCPs help medical device software manufacturers manage updates, support AI systems, and enable agile compliance under evolving MDR and UKCA frameworks.
The AI Act Omnibus Explained: What the 2026 EU Rules Mean for Medical Device and IVD Manufacturers
Discover how the EU AI Act Omnibus affects AI medical devices and IVD manufacturers. Learn about the No Duplication principle, transparency rules, key 2026 and 2028 deadlines, and how MDR and IVDR compliance are converging with AI regulation.
Post-Deadline Reality Check: I’ve Submitted My IVDR Class C – Now What?
Submitted your IVDR Class C application? Learn what happens next, common causes of delays, review timelines, and why the September 2026 contract deadline is critical for maintaining EU market access.
